Page last updated: 2024-08-25

1-benzylimidazole and etomidate

1-benzylimidazole has been researched along with etomidate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Beugels, IP; Custers, EM; de Gooyer, M; Emmen, JM; Hermans, JJ; Hilbers, PA; Janssen, HM; Leysen, D; Ottenheijm, HC; Peeters, JW; Pieterse, K; Plate, R; Roumen, L; Smits, JF; Vekemans, JA1
Hartmann, RW; Hille, UE; Vock, CA; Zimmer, C1

Other Studies

3 other study(ies) available for 1-benzylimidazole and etomidate

ArticleYear
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Synthesis, biological evaluation, and molecular modeling of 1-benzyl-1H-imidazoles as selective inhibitors of aldosterone synthase (CYP11B2).
    Journal of medicinal chemistry, 2010, Feb-25, Volume: 53, Issue:4

    Topics: 18-Hydroxycorticosterone; Animals; Benzyl Compounds; Catalytic Domain; Cell Line; Cricetinae; Cricetulus; Cytochrome P-450 CYP11B2; Fadrozole; Humans; Imidazoles; Models, Molecular; Molecular Dynamics Simulation; Protein Binding; Stereoisomerism; Structure-Activity Relationship

2010
First Selective CYP11B1 Inhibitors for the Treatment of Cortisol-Dependent Diseases.
    ACS medicinal chemistry letters, 2011, Jan-13, Volume: 2, Issue:1

    Topics:

2011